Morishita Jintan Co., Ltd. (TYO:4524)

Market Cap	9.12B
Revenue (ttm)	12.90B
Net Income (ttm)	581.00M
Shares Out	4.10M
EPS (ttm)	141.98
PE Ratio	15.67
Forward PE	n/a
Dividend	65.00 (2.89%)
Ex-Dividend Date	Mar 30, 2026

Volume	6,100
Average Volume	3,995
Open	2,251.00
Previous Close	2,251.00
Day's Range	2,222.00 - 2,268.00
52-Week Range	1,950.00 - 2,323.00
Beta	-0.09
RSI	58.60
Earnings Date	Feb 12, 2026

About Morishita Jintan

Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health foods in Japan. The company offers health food products, oral care product, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shop; domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200 and Bifidobacterium Pearl products through medical institutions. In ad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 356
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4524

Financial Performance

In 2024, Morishita Jintan's revenue was 12.77 billion, an increase of 2.90% compared to the previous year's 12.41 billion. Earnings were 547.00 million, a decrease of -21.52%.